- Home
- BMEZ vs XNCR Comparison
BMEZ vs XNCR Comparison
Compare BMEZ & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BMEZ | XNCR |
|---|---|---|
| Founded | N/A | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 923.8M | 1.1B |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | BMEZ | XNCR |
|---|---|---|
| Price | $15.28 | $17.08 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $22.44 |
| AVG Volume (30 Days) | 391.3K | ★ 728.9K |
| Earning Date | 01-01-0001 | 11-05-2025 |
| Dividend Yield | ★ 8.71% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.54 | N/A |
| Revenue | N/A | ★ $150,132,000.00 |
| Revenue This Year | N/A | $18.81 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $30.17 | ★ N/A |
| Revenue Growth | N/A | ★ 38.16 |
| 52 Week Low | $12.93 | $6.92 |
| 52 Week High | $16.95 | $26.59 |
Technical Indicators
Market Signals| Indicator | BMEZ | XNCR |
|---|---|---|
| Relative Strength Index (RSI) | 54.21 | 57.23 |
| Support Level | $15.10 | $16.58 |
| Resistance Level | $15.67 | $18.69 |
| Average True Range (ATR) | 0.24 | 0.97 |
| MACD | -0.01 | -0.08 |
| Stochastic Oscillator | 54.60 | 51.06 |
Price Performance
Historical ComparisonAbout BMEZ BlackRock Health Sciences Term Trust of Beneficial Interest
BlackRock Health Sciences Trust II is a closed-ended management investment company. The investment objective is to provide total return through a combination of current income and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of energy and natural resources companies and equity derivatives with exposure to the energy and natural resources industry.
About XNCR Xencor Inc.
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.